Predicting treatment response in central nervous system diseases
The commonly-used epilepsy drug, valproic acid (VPA), can have a highly beneficial effect on some babies born with spinal muscular atrophy (SMA), the number one genetic killer during early infancy. But in about two-thirds ...
Jun 23, 2012
0
0